AK

Ashokkumar Kanaiyalal Patel

Active Director Director DIN 07077268
DIN 07077268 First appointment Sep 2017 Primary industry Pharma
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since Sep 2017
Shareholding value •••• Premium profile

About Ashokkumar Kanaiyalal Patel

Data last updated:

Ashokkumar Kanaiyalal Patel is a Director at Ascare Pharma Private Limited (since 2017). The company operates in Pharma. Ascare Pharma Private Limited reported revenue of ₹1.17 Cr (FY 2025).

DIN 07077268
Primary Designation Director
Industry Pharma
First Appointment 13 Sep 2017
Oldest Company Age 9 yrs
Largest company Ascare Pharma Private Limited · ₹1.17 Cr (FY 2025)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Ascare Pharma Private Limited U51909GJ2017PTC099070
Director13 Sep 20172017₹1.17 Cr (FY 2025)Active

Board colleagues of Ashokkumar Kanaiyalal Patel

Directorship timeline

Open interactive timeline →
Ascare Pharma Private Limited
Premium access

Shareholding and investment profile for Ashokkumar Kanaiyalal Patel

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Ashokkumar Kanaiyalal Patel

Ashokkumar Kanaiyalal Patel currently holds 1 directorship: Ascare Pharma Private Limited (Director, since 13 Sep 2017, revenue ₹1.17 Cr (FY 2025)).

Ashokkumar Kanaiyalal Patel was first appointed on 13 Sep 2017 as Director at Ascare Pharma Private Limited.

The current boards of Ashokkumar Kanaiyalal Patel's companies include Rakeshkumar Vadilal Patel (Ascare Pharma Private Limited), Tejalben Ashokkumar Patel (Ascare Pharma Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available